Replies to post #106736 on Biotech Values

[genisi]

I don't see why non-compliance would be so different in both arms. So, hard to believe resistance to TMC278 could be largely explained by that. There should be another mechanism by which patients who took TMC278 had more mutations that emerged during treatment.